ψ-Bufarenogin, a lead compound of anti-cancer drug
被引:4
|
作者:
Ding, Jin
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Natl Ctr Liver Canc, Shanghai, Peoples R ChinaSecond Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Natl Ctr Liver Canc, Shanghai, Peoples R China
Ding, Jin
[1
]
Wang, Hongyang
论文数: 0引用数: 0
h-index: 0
机构:
Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Natl Ctr Liver Canc, Shanghai, Peoples R ChinaSecond Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Natl Ctr Liver Canc, Shanghai, Peoples R China
Wang, Hongyang
[1
]
机构:
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Natl Ctr Liver Canc, Shanghai, Peoples R China
机构:
Keio Univ, Div Basic Biol Sci, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, JapanKeio Univ, Div Basic Biol Sci, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan
Shibata, Shoyo
论文数: 引用数:
h-index:
机构:
Matsushita, Maiko
Saito, Yoshimasa
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Div Pharmacotherapeut, Fac Pharm, Minato Ku, Tokyo, JapanKeio Univ, Div Basic Biol Sci, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan
Saito, Yoshimasa
Suzuki, Takeshi
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Div Basic Biol Sci, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, JapanKeio Univ, Div Basic Biol Sci, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan
机构:Queen Mary University of London,Inositide Signalling Group, Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry